Clinical test of Kebuzon versus phenylbutazone in rheumatoid arthritis.
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008124:Locomotion; D008297:Male; D008875:Middle Aged; D009068:Movement; D009325:Nausea / Q000139:chemically induced; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D013272:Stomach Diseases / Q000139:chemically induced; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced
D000700:Analgesics; D010653:Phenylbutazone